NCT06940557View on ClinicalTrials.gov

Efficacy And Tolerability Of Alpha Lipoic Acid And Vitamin B Preparation In Carpal Tunnel Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Carpal Tunnel Syndrome (CTS)
Interventions
DRUG

Bionerv

alpha lipoic acid; 300mg, methylcobalamin; 500mcg, vitamin B1; 39mg and vitamin B6; 8mg, 2 tablets once daily

DRUG

Placebo

maltodextrin, microcrystalline cellulose, tricalcium phosphate, silicon gioxide, magnesium stearate 2 tablets once daily

Trial Locations (1)

43000

Hospital Sultan Abdul Aziz Shah, Serdang

Sponsors
All Listed Sponsors
collaborator

BREGO Life Sciences Sdn Bhd

UNKNOWN

lead

Universiti Putra Malaysia

OTHER

NCT06940557 - Efficacy And Tolerability Of Alpha Lipoic Acid And Vitamin B Preparation In Carpal Tunnel Syndrome | Biotech Hunter | Biotech Hunter